TomoTherapy Incorporated (NASDAQ: TTPY) today announced that management will participate in two investment community conferences in early January 2008.
Steve Hathaway, CFO, will present at the Needham & Company, LLC 10th Annual Growth Conference on Tuesday, Jan. 8, 2008, at 4:00 p.m. ET. The conference is taking place Jan. 8-11, 2008, at the New York Palace Hotel in New York City.
On Thursday, Jan. 10, 2008, Dr. Fred Robertson, CEO, and Steve Hathaway will present at the JPMorgan Healthcare Conference at 8:30 a.m. PT. The conference is being held Jan. 7-10, 2008, at the Westin St. Francis in San Francisco.
A live Webcast of both presentations will be available on the investor relations page of TomoTherapy’s Web site at www.TomoTherapy.com. For those who are unable to listen to the live presentation, an archive of the Webcast will be available on the company’s site for 30 days following the presentation.
About TomoTherapy Incorporated
TomoTherapy Incorporated has developed, manufactures and sells the TomoTherapy® Hi·Art® treatment system, an advanced radiation therapy system for the treatment of a wide variety of cancers. The Hi·Art treatment system combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. The company completed its initial public offering in May 2007 and its stock is traded on the NASDAQ Global Market under the symbol TTPY. Effective Jan. 2, 2008, the company’s symbol will change to TOMO. To learn more about TomoTherapy, please visit our Web site at www.TomoTherapy.com.
©2007 TomoTherapy Incorporated. All rights reserved. TomoTherapy, the TomoTherapy logo and Hi·Art are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated.
Contacts:
Investor Contact:
Stephen
C. Hathaway, Chief Financial Officer
608.824.2800
shathaway@tomotherapy.com